Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000929638-25-002664
Filing Date
2025-07-22
Accepted
2025-07-22 17:15:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10414
  Complete submission text file 0000929638-25-002664.txt   12202
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 1599 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 1599 INDUSTRIAL ROAD SAN CARLOS CA 94070 (650) 980-9099
Biomea Fusion, Inc. (Subject) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92506 | Film No.: 251141035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)